Prof Rodney Hicks
Honorary Clinical Professor
Department of Medicine
1010 Scholarly works
27 Projects
HIGHLIGHTS
2020
Research grants (ARC, NHMRC, MRFF)
Evaluation of Fibroblastic Activation Protein Inhibitors (FAPI) as a Novel Radiopharmaceutical Targeting Cancer-Associated Fibroblasts for the Diagnosis and Treatment of Patients With Cancer of Unknown Primary: The FAPI-CUP Trial
2018
Journal article
Cold kit for prostate-Specific membrane antigen (PSMA) PET imaging: Phase 1 study of 68Ga-Tris (Hydroxypyridinone)-PSMA PET/CT in patients with prostate cancer
DOI: 10.2967/jnumed.117.1995542018
Journal article
Ibrutinib plus venetoclax for the treatment of mantle-cell lymphoma
DOI: 10.1056/NEJMoa17155192017
Conference Proceedings
Lutetium-177 PSMA (LuPSMA) theranostics phase II trial: Efficacy, safety and QoL in patients with castrate-resistant prostate cancer treated with LuPSMA
DOI: 10.1093/annonc/mdx370.0022017
Research Grant
Acrf Tumour Heterogeneity Program
2017
Conference Proceedings
Cold Kit PSMA Imaging: First In-Man Study of 68Ga-THP-PSMA PET/CT in Patients with Prostate Cancer
2017
Research grants (other domestic)
Novel Approaches for Overcoming Resistance to Therapies for Advanced Melanoma
RECENT SCHOLARLY WORKS
2026
Journal article
My Life as a “Theranostician”: A commentary on the evolution of theranostics
DOI: 10.1038/s44303-026-00171-w2026
Journal article
Fully Automated Segmentation of [18F]FDG and [68Ga]/[18F]PSMA PET/CT Images via Data-Centric Deep Learning
DOI: 10.2967/jnumed.126.2728522026
Journal article
Targeted Radionuclide Therapy: Current Landscape and Combination Approaches to Improve Oncology Outcomes
DOI: 10.1158/1078-0432.CCR-25-47202026
Journal article
Tumor-Intrinsic Blood and Imaging Correlatives in Advanced Prostate Cancer Treated with Combination Radiopharmaceutical Therapy and Immunotherapy.
DOI: 10.2967/jnumed.126.2732662026
Journal article
Diagnostic and therapeutic impact of genomic testing in neuroendocrine neoplasms
DOI: 10.1530/ERC-26-02252026
Journal article
Somatostatin receptor PET response assessment framework for patients with neuroendocrine tumours (V1.0): a modified Delphi consensus from the European Neuroendocrine Tumor Society (endorsed by EANM and NANETS)
DOI: 10.1016/S1470-2045(26)00145-22026
Journal article
Whole genome and exome sequencing of pancreatic neuroendocrine tumour to investigate PRRT response
DOI: 10.1530/ERC-26-02072026
Journal article
Optimal Imaging Strategies After Negative PSMA PET/CT Results in Patients With Prostate Cancer Biochemical Recurrence: AJR Expert Panel Narrative Review.
DOI: 10.2214/AJR.26.35081